Arrowhead pharmaceuticals Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Arrowhead pharmaceuticals Contact Number

Contact Arrowhead Pharmaceuticals, Inc.

6 hours ago Arrowheadpharma.com Show details

626-304-3400

Vince Anzalone, CFA Arrowhead Pharmaceuticals, Inc. Call: 626-304-3400 [email protected] Brian Ritchie LifeSci Advisors Call: 212-915-2578 [email protected]

Category: Contact SupportShow more

Contact Us Arrowhead Pharmaceuticals Inc.

1 hours ago Ir.arrowheadpharma.com Show details

212-915-2578

Contact Us Brian Ritchie LifeSci Advisors 212-915-2578 [email protected] Vince Anzalone, CFA Arrowhead Pharmaceuticals, Inc. 626-304-3400

Category: Contact SupportShow more

Arrowhead Pharmaceuticals Crunchbase Company …

8 hours ago Crunchbase.com Show details

(626) 304-3400

Contact Email [email protected] Phone Number (626) 304-3400. Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases.

Founded: 1989

Category: Contact NumberShow more

Arrowhead Pharmaceuticals, Inc. in Hanceville, Alabama

Just Now Npino.com Show details

256-287-3333

Arrowhead Pharmaceuticals, Inc. (ARROWHEAD PHARMACEUTICALS, INC.) is a General Pharmacy in Hanceville, Alabama.The NPI Number for Arrowhead Pharmaceuticals, Inc. is 1295179810. The current location address for Arrowhead Pharmaceuticals, Inc. is 561 Al Highway 69 S, , Hanceville, Alabama and the contact number is 256-287-3333 and fax …

Category: Contact NumberShow more

Arrowhead Pharmaceuticals Target the Gene Silence the

8 hours ago Arrowheadpharma.com Show details

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. Learn More.

Category: Contact NumberShow more

Arrowhead Pharmaceuticals, Inc. Company Profile …

3 hours ago Dnb.com Show details

Arrowhead Pharmaceuticals, Inc. is located in Madison, WI, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Arrowhead Pharmaceuticals, Inc. has 4 employees at this location. (Employees figure is modelled). There are 12 companies in the Arrowhead Pharmaceuticals, Inc. corporate family.

Category: Contact NumberShow more

Arrowhead Pharmaceuticals Company Profile Office

5 hours ago Craft.co Show details

Arrowhead Pharmaceuticals has 134 employees across 3 locations and $168.8 M in annual revenue in FY 2019. See insights on Arrowhead Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Contact NumberShow more

Arrowhead Pharmaceuticals, Inc. in Dresher, PA Company Info

3 hours ago Bizapedia.com Show details

Arrowhead Pharmaceuticals, Inc. is a Pennsylvania Foreign Profit Corporation filed On June 24, 2021. The company's filing status is listed as Active and its File Number is 7313276. The Registered Agent on file for this company is located at 807 Dresher Woods Drive, Dresher, PA …

Location: PA

Category: Contact NumberShow more

EX4.1 SEC

2 hours ago Sec.gov Show details

ARROWHEAD PHARMACEUTICALS, INC. ***** 000000 ***** PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE . For value received, hereby sell, assign and transfer unto If you do not keep in contact with us or do not have any .

Category: Contact NumberShow more

Arrowhead Pharmaceuticals How Have the Numbers Shaped Up

Just Now Stockmarketdaily.co Show details

The P/E ratio of Arrowhead Pharmaceuticals is -275.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Arrowhead Pharmaceuticals has a P/B Ratio of 26.77. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Category: Contact NumberShow more

Read This Before Buying Arrowhead Pharmaceuticals, Inc

8 hours ago Nasdaq.com Show details

1. It's quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, such insiders must disclose their trading activities, and not trade on inside information. We don't think shareholders should simply follow insider transactions. But equally, we would consider it foolish to ignore insider transactions altogether. As Peter Lynch said, 'insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise'.

Category: Contact NumberShow more

Arrowhead Pharmaceuticals LinkedIn

8 hours ago Linkedin.com Show details

Arrowhead Pharmaceuticals Pharmaceuticals Pasadena, CA 19,131 followers Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the …

Category: Contact NumberShow more

Arrowhead Pharmaceuticals Wikipedia

5 hours ago En.wikipedia.org Show details

Arrowhead Pharmaceuticals is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through RNA interference (RNAi) mechanisms of action. The company focuses on treatments for Hepatitis B, the liver disease associated with alpha 1-antitrypsin deficiency (AATD) and cardiovascular disease. …

Category: Contact NumberShow more

Adeoye Y. Olukotun Net Worth, Biography & Insider Trading

4 hours ago Insidertrades.com Show details

(626) 304-3400

The corporate mailing address for Dr. Olukotun and other Arrowhead Pharmaceuticals executives is 177 E. Colorado Blvd Suite 700, Pasadena CA, 91105. Arrowhead Pharmaceuticals can also be reached via phone at (626) 304-3400 and via email at [email protected]

Email: [email protected]
Phone: (626) 304-3400
Occupation: Director, Arrowhead Pharmaceuticals

Category: Contact NumberShow more

Contact Us Global Pharma Times

5 hours ago Globalpharmatimes.com Show details

For editorial articles/press releases: [email protected] To advertise with us: [email protected] For careers: [email protected] For any other queries: contact@tradenewsnetwork.in Contact number: +9181694 44018 Email id: [email protected]

Category: Contact SupportShow more

Pharmacy Of The Woods in Lake Arrowhead, California

Just Now Npino.com Show details

909-336-3999

Pharmacy Of The Woods (TERRY L BLASINGAME INC) is a Community/Retail Pharmacy in Lake Arrowhead, California.The NPI Number for Pharmacy Of The Woods is 1912262809. The current location address for Pharmacy Of The Woods is 28200 Highway 189 Ste N-150, , Lake Arrowhead, California and the contact number is 909-336-3999 and fax number is 909-336 …

Category: Contact NumberShow more

San Bernardino County Pharmacy Arrowhead Regional

1 hours ago Arrowheadregional.org Show details

324 877-873

Arrowhead Regional Medical Center Inpatient, Outpatient 400 N. Pepper Ave. Colton, CA 92324 877-873-2762 More Information /

Category: Contact NumberShow more

Douglass B. Given Net Worth, Biography & Insider Trading

2 hours ago Insidertrades.com Show details

(626) 304-3400

The corporate mailing address for Dr. Given and other Arrowhead Pharmaceuticals executives is 177 E. Colorado Blvd Suite 700, Pasadena CA, 91105. Arrowhead Pharmaceuticals can also be reached via phone at (626) 304-3400 and via email at [email protected]

Email: [email protected]
Phone: (626) 304-3400
Occupation: Director, Arrowhead Pharmaceuticals

Category: Contact NumberShow more

Global RNAinterference (RNAi) Market 2021 26

Just Now Mordorintelligence.com Show details

Companies like Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Gradalis, miRagen Therapeutics, among others, hold a substantial market share in the RNA-interference (RNAi) market. Various developments have recently been taking place in the market, such as in November 2017, Arcturus Therapeutics merged with Alcobra Ltd.

Category: Contact NumberShow more

Arrowhead Pharmaceuticals Funding, Financials, Valuation

7 hours ago Crunchbase.com Show details

Arrowhead Pharmaceuticals has raised a total of $449.9M in funding over 9 rounds. Their latest funding was raised on Dec 6, 2019 from a Post-IPO Equity round. Arrowhead Pharmaceuticals is registered under the ticker NASDAQ:ARWR . Arrowhead Pharmaceuticals is funded by 4 investors. Silence Therapeutics and OrbiMed are the most recent investors.

Category: Contact NumberShow more

$ARWR: JUST IN – New data and price prediction is out now

9 hours ago Wallstreetfacts.com Show details

The 52-week high for Arrowhead Pharmaceuticals Inc is $93.66 and the low is $44.29. We will be moving onto the number of outstanding shares. One is that you can use shares outstanding to calculate the market capitalization, the total value, of a corporation.

Category: Contact NumberShow more

Arrowhead Electrical Products Company Contact Information

8 hours ago Adapt.io Show details

Revenue $10 - 50M. Head Count 250 - 1000. Industry Manufacturing. Location Circle Pines, Minnesota, United States. Access all contacts. Access similar companies.

Category: Contact SupportShow more

Arrowhead Pharmaceuticals: Number of Employees 20062021

2 hours ago Macrotrends.net Show details

Dividend Yield History. Number of Employees. Interactive chart of Arrowhead Pharmaceuticals (ARWR) annual worldwide employee count from 2006 to 2021. Arrowhead Pharmaceuticals total number of employees in 2020 was 232, a 112.84% increase from 2019. Arrowhead Pharmaceuticals total number of employees in 2019 was 109, a 14.74% increase from 2018.

Category: Contact NumberShow more

Why Are Arrowhead Pharmaceuticals Shares Down 20%?

5 hours ago Rttnews.com Show details

Published: 7/2/2021 10:05 AM ET. Shares of Arrowhead Pharmaceuticals, Inc. ( ARWR) tanked nearly 20% on Friday morning after the drug company said it has paused a mid-stage study of ARO-ENaC, the company's investigational treatment for patients with cystic fibrosis. ARWR is currently trading at $68.73, down $16.23 or 19.10%, on the Nasdaq.

Category: Contact NumberShow more

Arrowhead Pharmaceuticals (ARWR) Company Profile

6 hours ago Stockanalysis.com Show details

Company profile for Arrowhead Pharmaceuticals, including a description, list of executives, contact details and other key facts. Company profile for Arrowhead Pharmaceuticals, including a description, list of executives, contact details and other key facts. CUSIP Number: 042797100: ISIN Number: US04280A1007: Employer ID: 46-0408024: …

Category: Contact NumberShow more

Financials & Filings Arrowhead Pharmaceuticals Inc.

2 hours ago Ir.arrowheadpharma.com Show details

The Investor Relations website contains information about Arrowhead Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial analysts.

Category: Contact NumberShow more

Sustainable Arrowhead Pharmaceuticals's ESG performance data

3 hours ago Sustainable.com Show details

Biotechnology Arrowhead Pharmaceuticals. Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of …

Category: Contact NumberShow more

ARROWHEAD AUSTRALIA PTY LTD Company Profile BRISBANE

1 hours ago Dnb.com Show details

ARROWHEAD AUSTRALIA PTY LTD is located in BRISBANE CITY, QUEENSLAND, Australia and is part of the Scientific Research and Development Services Industry. ARROWHEAD AUSTRALIA PTY LTD has 42 total employees across all of its locations and generates $3,028 in sales (USD). (Employees figure is modelled).

Category: Contact NumberShow more

Arrowhead Pharmaceuticals, Inc (ARWR) Q4 2020 Earnings

9 hours ago Fool.com Show details

Arrowhead Pharmaceuticals, Inc (ARWR) Q4 2020 Earnings Call Transcript ARWR earnings call for the period ending September 30, 2020.

Category: Contact NumberShow more

Arrowhead Pharmaceuticals, Inc. NASDAQ:ARWR Stock

7 hours ago Realmoney.thestreet.com Show details

Arrowhead Pharmaceuticals Is Flying Higher on the Charts. Before I give my recommendation I want to visit with the charts and indicators. Oct 18, 2019 3:10 PM EDT. Contact Customer Service.

Category: Contact NumberShow more

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) Has Slid

7 hours ago Marketingsentinel.com Show details

Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR)’s traded shares stood at 0.71 million during the last session, with the company’s beta value hitting 1.26. At the close of trading, the stock’s price was $60.33, to imply an increase of 2.29% or $1.35 in intraday trading. The ARWR share’s 52-week

Category: Contact NumberShow more

Is Arrowhead Pharmaceuticals (ARWR) A Good Stock To Buy Now?

7 hours ago Finance.yahoo.com Show details

In Q1 2021, the number of bullish hedge fund positions on Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) stock decreased by about 17% from the previous quarter (see the chart here), so a number of

Category: Contact NumberShow more

Arrowhead slams brakes on earlystage cystic fibrosis

7 hours ago Fiercebiotech.com Show details

Arrowhead Pharmaceuticals is pausing a phase 1/2 study for an RNAi therapeutic after rats in a preclinical study showed unexpected lung inflammation. The Pasadena, California-based

Category: Contact NumberShow more

What Do Analysts Think Of Arrowhead Pharmaceuticals Inc

7 hours ago Baxterreport.com Show details

Arrowhead Pharmaceuticals Inc. (ARWR) saw an uptrend of 5.27% in the recent trading with $63.27 being its most recent. The current price level -32.45% lower than the highest price of $93.66 marked by the stock while trading over the past 52-weeks, whereas it is 42.85% higher than the lowest price of $44.29 the company dropped to over past 52-weeks.

Category: Contact NumberShow more

ARWR Stock: Analyst Bullish On Biotech Company's RNAi

9 hours ago Investors.com Show details

Arrowhead Pharmaceuticals grabbed an upgrade Friday as ARWR stock has rocketed 159% since October on enthusiasm for the biotech company's RNAi platform.. X. On the stock market today, ARWR stock

Category: Tech SupportShow more

Arrowhead Pharmaceuticals Is A LongTerm Investment To

2 hours ago Seekingalpha.com Show details

Arrowhead could also receive up to $420 million in option and milestone payments related to ARO-LPA as well as low-double-digit royalties. Amgen has already started a Phase 1 trial of what it is

Category: Contact NumberShow more

Arrowhead Pharmaceuticals hiring Sr. Scientist, Cancer

2 hours ago Linkedin.com Show details

Posted 5:44:18 PM. The Position Arrowhead is seeking a senior biologist to join our Biology Department. The candidate…See this and similar jobs on LinkedIn.

Category: Contact NumberShow more

ARWR: New Program Targeting Complement C3 Highlights

2 hours ago Finance.yahoo.com Show details

Recently, the company has announced the following additions to the pipeline: 1) ARO-C3: This program is targeting complement component 3 (C3). The complement pathway is a part of the innate immune

1. Author: Zacks Small Cap Research

Category: Contact NumberShow more

Takeda Pharmaceutical Company Limited (TAK) Company

5 hours ago Stockanalysis.com Show details

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products worldwide. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity …

Category: Contact NumberShow more

Arrowhead Pharmaceuticals Inc (ARWR) Price Targets From

6 hours ago Stocknews.com Show details

Arrowhead Pharmaceuticals Inc's number of analysts covering the stock is greater than 90.74% of Pharmaceutical Products stocks. Arrowhead Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 22.72% of Pharmaceutical Products stocks.

Category: Contact NumberShow more

ARWR Stock Price Arrowhead Pharmaceuticals Corp. Stock

8 hours ago Marketwatch.com Show details

Arrowhead Pharmaceuticals stock price target raised to $46 from $32 at B. Riley FBR. Aug. 19, 2019 at 7:30 a.m. ET by Tomi Kilgore. Barron's.

Category: Contact NumberShow more

Arrowhead Pharmaceuticals Stock Price Target and Analyst

1 hours ago Pricetargets.com Show details

(626) 304-3400

Arrowhead Pharmaceuticals' physical mailing address is 177 E. Colorado Blvd Suite 700, Pasadena CA, 91105. The biotechnology company's listed phone number is (626) 304-3400 and its investor relations email address is [email protected] The official website for Arrowhead Pharmaceuticals is www.arrowheadpharma.com.

Category: Contact NumberShow more

Have Insiders Sold Arrowhead Pharmaceuticals, Inc. (NASDAQ

2 hours ago Nasdaq.com Show details

Contact; Quick Links We'd be surprised if Arrowhead Pharmaceuticals, Inc I reckon it's a good sign if insiders own a significant number of shares in the company. Arrowhead Pharmaceuticals

Category: Contact NumberShow more

Hereditary Angioedema Market to Surge beyond US$ 3.4

Just Now Coherentmarketinsights.com Show details

For instance, in 2016, RNAi-based candidate ARC-F12 by Arrowhead Pharmaceuticals is currently in preclinical development and is a potential treatment for factor XII (F12) mediated diseases. The RNAi based candidate is expected to present opportunities in the treatment of hereditary angioedema, thus the Arrowhead is currently conducting studies

Category: Contact NumberShow more

Will Arrowhead Pharmaceuticals Inc (ARWR) Outperform the

Just Now Investorsobserver.com Show details

Arrowhead Pharmaceuticals Inc is near the top in its sector according to InvestorsObserver. ARWR gets an overall rating of 44. That means it scores higher than 44% of stocks. Arrowhead Pharmaceuticals Inc gets a 76 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

Category: Contact NumberShow more

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Given

1 hours ago Marketbeat.com Show details

Arrowhead Pharmaceuticals has a twelve month low of $42.44 and a twelve month high of $93.66. The firm has a market cap of $6.32 billion, a P/E ratio of -49.31 and a beta of 1.23. Arrowhead Pharmaceuticals (NASDAQ:ARWR) last released its quarterly earnings results on Wednesday, August 4th.

Category: Contact NumberShow more

Arrowhead Pharmaceuticals: Buy the Dip? The Motley Fool

Just Now Fool.com Show details

In a five-patient study, ARO-AAT reduced the number of mutating proteins associated with Alpha-1 antitrypsin deficiency (AATD), a hereditary liver disease, by 77% to 97%. The disease is prevalent

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is arrowhead pharmaceuticals inc?

Arrowhead Pharmaceuticals is a publicly traded ( NASDAQ: ARWR) biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through RNA interference (RNAi) mechanisms of action.

What is the price target for arrowhead research?

B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Arrowhead Research (ARWR) today and set a price target of $32.

When did arrowhead pharmaceuticals license aro hbv?

On Oct. 31, 2018, Arrowhead Pharmaceuticals Inc. closed on a $3.7 Billion License and Collaboration Agreements with Janssen to develop and commercialize ARO-HBV.

When did arrowhead get a license from amgen?

In September 2016, Arrowhead entered into two collaboration and licensing agreements with Amgen. Under the deals, Amgen received a worldwide exclusive license to Arrowhead’s ARO-LPA RNAi program and an option to a worldwide exclusive license for ARO-AMG1, both for cardiovascular disease.

Brand New Updated

Popular Brands

Amazon
Abbvie
Aia
Asml
Amgen
Att
Apple
Adobe
Aptar
Acc
Adidas
Aak
Aes